Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Valeant Pharmaceuticals Intl Inc (VRX.TO)

Valeant Pharmaceuticals Intl Inc (VRX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,758,416
  • Shares Outstanding, K 349,299
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -1.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade VRX.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.64
  • Most Recent Earnings -7.68 on 03/31/18
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 1.000 on 11/10/10
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 1.04
  • Number of Estimates 6
  • High Estimate 1.19
  • Low Estimate 0.91
  • Prior Year 1.41
  • Growth Rate Est. (year over year) -26.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.80 +3.36%
on 07/06/18
35.73 -13.80%
on 06/15/18
-4.09 (-11.72%)
since 06/13/18
3-Month
21.10 +45.97%
on 04/16/18
36.02 -14.49%
on 06/13/18
+9.18 (+42.46%)
since 04/13/18
52-Week
14.01 +119.84%
on 11/02/17
36.02 -14.49%
on 06/13/18
+8.78 (+39.87%)
since 07/13/17

Most Recent Stories

More News
Choroidal Neovascularization Market: Facts, Figures and Analytical Insights, 2020 to 2027| Regeneron Pharmaceuticals Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Gilead Sciences Inc and Others

The recent published research report sheds light on critical aspects of the such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report...

BAYRY : 15.7300 (-1.47%)
GILD : 66.61 (-0.91%)
NVS : 93.01 (-1.21%)
PFE : 38.81 (-1.70%)
QLTI : 1.95 (+6.56%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Varicella Zoster Infection Treatment Market 2021 With Covid-19 Impact on Market Share, Size, Revenue, Latest Trends, Business Boosting Strategies, CAGR Status, Growth Opportunities and Forecast 2027

The is segmented on the lines of its drug type, route of administration and regional. Basis of drug type is segmented into Acyclovir, Valacyclovir and Famciclovir. Based on route of administration it...

ABT : 110.33 (-1.16%)
GSK : 39.84 (-1.80%)
NVS : 93.01 (-1.21%)
PFE : 38.81 (-1.70%)
TEVA : 10.12 (-2.69%)
VRX.TO : 30.80 (-3.33%)
Dermatological Therapeutics Market, June 2021 Report On 2021 Recovering From Covid-19 Outbreak | Know More about Industry Insights, Drivers, Shares, Revenue, Value and Volume Analysis, Top Trends and Future Scope to 2030

In a recently published report, Dermatological Therapeutics Market. report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players...

AGN : 193.02 (+0.02%)
VRX.TO : 30.80 (-3.33%)
Actinic Keratosis Market Boosting the Growth Worldwide:Valeant Pharmaceuticals International, Novartis, Tolmar, DUSA Pharmaceuticals_

MarketInsightsReports has published a latest market research report on market report gives out an in-depth analysis of the market scenario and covers the segmentation of the market in an insightful manner....

DUSA : 34.31 (-1.38%)
NVS : 93.01 (-1.21%)
VRX.TO : 30.80 (-3.33%)
Global Cannabinoid Drugs Market Things to Focus on to Ensure Long-term Success | Abbott Laboratories, Valeant Pharmaceuticals International, Indevus Pharmaceuticals, and Others

Cannabinoid Drugs are natural occurring recreational drugs that are used to treat chronic pain, anorexia, and nausea & vomiting. The cannabinoid is used for a group of drugs that are structurally related...

ABT : 110.33 (-1.16%)
IDEV : 67.00 (-1.87%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery System Market Size, Share, Trends, Analysis and Forecast 2027

The report on Topical Drug Delivery System provides the clients with a comprehensive analysis of crucial driving factors, consumer behavior, growth trends, product utilization, key player analysis, brand...

BAYRY : 15.7300 (-1.47%)
CRRTF : 0.6513 (+0.20%)
VRX.TO : 30.80 (-3.33%)
Otoscope Devices Market Size Volume, Share, Demand growth, Business Opportunity by 2028

The scope of the report includes a detailed study of global and regional markets for Global Otoscope Devices Market with the reasons given for variations in the growth of the industry in certain regions....

AGN : 193.02 (+0.02%)
CYNO : 66.15 (+0.23%)
NSRGY : 125.3100 (-0.52%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
Ocular Inflammation Treatment Market Share Growth, Size Value, Trends, Rigonal outlook by 2028

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Allergan Plc, Valeant...

AKRX : 0.0900 (-51.01%)
ALIM : 9.50 (-3.16%)
AGN : 193.02 (+0.02%)
NVS : 93.01 (-1.21%)
PFE : 38.81 (-1.70%)
VRX.TO : 30.80 (-3.33%)
Ophthalmic Drugs Market, June 2021 Report On Analysis 2021, Size, Top Players with Share, Total Revenues, Product Scope, Business Development and Opportunities till 2030

In a recently published report, Ophthalmic Drugs Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the...

BAYRY : 15.7300 (-1.47%)
NVS : 93.01 (-1.21%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Share, Trends | Industry Overview 2021 to 2026

Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional...

AVMXY : 7.8900 (+9.13%)
BMY : 66.47 (-0.45%)
GALE : 0.26 (-7.14%)
GSK : 39.84 (-1.80%)
NVS : 93.01 (-1.21%)
PRGO : 46.28 (-2.98%)
SNOA : 7.65 (-2.17%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 32.69
1st Resistance Point 31.74
Last Price 30.80
1st Support Level 30.30
2nd Support Level 29.81
3rd Support Level N/A

See More

52-Week High 36.02
Last Price 30.80
Fibonacci 61.8% 27.61
Fibonacci 50% 25.01
Fibonacci 38.2% 22.42
52-Week Low 14.01

See More

Business Summary

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar